Document is current

Article History

Received: 2 July 2025

Accepted: 12 January 2026

First Online: 4 February 2026

Declarations

:

: The authors declare no competing interests.

: The study was approved by the Ethics Committee of the Institute of Chemical Biology and Fundamental Medicine (No 1 from January 11 2022), with the patient’s informed consent, and conducted according to the Declaration of Helsinki. All animal procedures were carried out in strict accordance with the European Communities Council Directive 86/609/CEE. The experimental protocol was approved by the Committee on the Ethics of Animal Experiments at the Institute of Cytology and Genetics SB RAS (protocol no. 111 of 7 December 2021). This study was also conducted in accordance with the guidelines of the Animal Research: Reporting of In Vivo Experiments (ARRIVE).